143 related articles for article (PubMed ID: 1906778)
1. Pharmacodynamics of mitomycin C in cultured human bladder tumors.
Schmittgen TD; Wientjes MG; Badalament RA; Au JL
Cancer Res; 1991 Aug; 51(15):3849-56. PubMed ID: 1906778
[TBL] [Abstract][Full Text] [Related]
2. Expression of DT-diaphorase and cytochrome P450 reductase correlates with mitomycin C activity in human bladder tumors.
Gan Y; Mo Y; Kalns JE; Lu J; Danenberg K; Danenberg P; Wientjes MG; Au JL
Clin Cancer Res; 2001 May; 7(5):1313-9. PubMed ID: 11350900
[TBL] [Abstract][Full Text] [Related]
3. Bladder wall penetration of intravesical mitomycin C in dogs.
Wientjes MG; Dalton JT; Badalament RA; Drago JR; Au JL
Cancer Res; 1991 Aug; 51(16):4347-54. PubMed ID: 1907883
[TBL] [Abstract][Full Text] [Related]
4. Pharmacodynamics of doxorubicin in human bladder tumors.
Gan Y; Wientjes MG; Badalament RA; Au JL
Clin Cancer Res; 1996 Aug; 2(8):1275-83. PubMed ID: 9816297
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of intravesical mitomycin C in superficial bladder cancer patients.
Dalton JT; Wientjes MG; Badalament RA; Drago JR; Au JL
Cancer Res; 1991 Oct; 51(19):5144-52. PubMed ID: 1913640
[TBL] [Abstract][Full Text] [Related]
6. Penetration of mitomycin C in human bladder.
Wientjes MG; Badalament RA; Wang RC; Hassan F; Au JL
Cancer Res; 1993 Jul; 53(14):3314-20. PubMed ID: 8324743
[TBL] [Abstract][Full Text] [Related]
7. Correlation of human bladder tumor histoculture proliferation and sensitivity to mitomycin C with tumor pathobiology.
Schmittgen TD; Weaver JM; Badalament RA; Wientjes MG; Klein EA; Young DC; Au JL
J Urol; 1994 Nov; 152(5 Pt 1):1632-6. PubMed ID: 7933219
[TBL] [Abstract][Full Text] [Related]
8. Different pH dependency of mitomycin C activity in monolayer and three-dimensional cultures.
Yen WC; Schmittgen T; Au JL
Pharm Res; 1996 Dec; 13(12):1887-91. PubMed ID: 8987090
[TBL] [Abstract][Full Text] [Related]
9. Low dose suramin as a chemosensitizer of bladder cancer to mitomycin C.
Xin Y; Lyness G; Chen D; Song S; Wientjes MG; Au JL
J Urol; 2005 Jul; 174(1):322-7. PubMed ID: 15947683
[TBL] [Abstract][Full Text] [Related]
10. Mitomycin C sensitivity in human bladder cancer cells: possible role of glutathione and glutathione transferase in resistance.
Xu BH; Gupta V; Singh SV
Arch Biochem Biophys; 1994 Jan; 308(1):164-70. PubMed ID: 8311448
[TBL] [Abstract][Full Text] [Related]
11. Cultured human bladder tumors for pharmacodynamic studies.
Schmittgen TD; Au JL; Wientjes MG; Badalament RA; Drago JR
J Urol; 1991 Jan; 145(1):203-7. PubMed ID: 1898521
[TBL] [Abstract][Full Text] [Related]
12. Antitumor activity of 7-N-[[2-[[2-(gamma-L-glutamylamino)ethyl]dithio]ethyl]]-mitomycin C.
Morimoto M; Ashizawa T; Ohno H; Azuma M; Kobayashi E; Okabe M; Gomi K; Kono M; Saitoh Y; Kanda Y
Cancer Res; 1991 Jan; 51(1):110-5. PubMed ID: 1988076
[TBL] [Abstract][Full Text] [Related]
13. [Inhibitory effects of aromatic retinoic acid analog, administered alone or in combination with mitomycin C, on the in vitro growth of rat bladder carcinoma cells].
Fujita J; Yoshida O
Hinyokika Kiyo; 1984 Nov; 30(11):1627-31. PubMed ID: 6241424
[TBL] [Abstract][Full Text] [Related]
14. Sarcoma-180 cells and human colorectal tumor cells under in vitro hypoxic conditions are more sensitive to mitomycin C and carboquone.
Kusumoto T; Maehara Y; Sakaguchi Y; Kohnoe S; Emi Y; Sugimachi K
Eur J Surg Oncol; 1991 Aug; 17(4):358-63. PubMed ID: 1908390
[TBL] [Abstract][Full Text] [Related]
15. Modulating effect of mitomycin or cisplatin on lymphokine-activated killer cell proliferation and antitumor activity to bladder cancer cell lines in vitro.
Wang ZP; Qing DS; Shi BG; Chen YR; Liu GD
Zhongguo Yao Li Xue Bao; 1998 Jul; 19(4):369-72. PubMed ID: 10375787
[TBL] [Abstract][Full Text] [Related]
16. [Mechanism of resistance to mitomycin C in a human bladder cancer cell line].
Xu B; Sun Y; Singh SV
Zhonghua Zhong Liu Za Zhi; 1995 Sep; 17(5):343-6. PubMed ID: 8697971
[TBL] [Abstract][Full Text] [Related]
17. Interferons modify in vitro proliferation of human bladder transitional cell carcinoma in the presence of doxorubicin and mitomycin C.
Okamoto E; Kinne RK; Sökeland J
J Urol; 1996 Oct; 156(4):1492-5. PubMed ID: 8808915
[TBL] [Abstract][Full Text] [Related]
18. Pharmacodynamics of taxol in human head and neck tumors.
Gan Y; Wientjes MG; Schuller DE; Au JL
Cancer Res; 1996 May; 56(9):2086-93. PubMed ID: 8616855
[TBL] [Abstract][Full Text] [Related]
19. [Rhein induces apoptosis in cancer cells and shows synergy with mitomycin].
Huang YH; Zhen YS
Yao Xue Xue Bao; 2001 May; 36(5):334-8. PubMed ID: 12584853
[TBL] [Abstract][Full Text] [Related]
20. Hyperthermic enhancement of cell killing by mitomycin C in mitomycin C-resistant Chinese hamster ovary cells.
Wallner KE; Banda M; Li GC
Cancer Res; 1987 Mar; 47(5):1308-12. PubMed ID: 3102043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
